What is the recommended follow-up for a patient with a history of one tubular adenoma found during a previous colonoscopy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2025 • View editorial policy

From the Guidelines

The recommended follow-up for a patient with a history of one tubular adenoma found during a previous colonoscopy is 7-10 years.

Key Considerations

  • The US Multi-Society Task Force recommends a follow-up interval of 7-10 years for patients with 1-2 tubular adenomas <10 mm 1, 2.
  • This recommendation is based on the risk of colorectal cancer outcomes, rather than just the risk of advanced adenoma during surveillance 2.
  • The quality of the baseline examination and patient preferences should also be taken into account when determining the follow-up interval 1.
  • Patients with a family history of CRC or other high-risk factors may require more intensive surveillance 3, 4.

Surveillance Intervals

  • The recommended surveillance intervals are as follows:
    • 1-2 tubular adenomas <10 mm: 7-10 years 1, 2
    • 3-4 tubular adenomas <10 mm: 3-5 years 1
    • Adenoma ≥10 mm: 3 years 1
    • Adenoma with tubulovillous or villous histology: 3 years 1
    • Adenoma with high-grade dysplasia: 3 years 1 ### Important Notes
  • These recommendations assume a complete examination to the cecum with adequate bowel preparation 1.
  • Patients with >10 adenomas or lifetime >10 cumulative adenomas may need to be considered for genetic testing 1.

From the Research

Follow-up Recommendations for Patients with a History of Tubular Adenoma

  • The recommended follow-up for a patient with a history of one tubular adenoma found during a previous colonoscopy is to have their next colonoscopy in five to 10 years 5.
  • This guideline applies to patients with one or two small (less than 1 cm) tubular adenomas, including those with only low-grade dysplasia 5.
  • A study published in 2017 found that endoscopists frequently recommend 3-year surveillance intervals instead of guideline-recommended intervals of 5 years or longer for individuals with low-risk adenomas, but found no significant differences in outcomes between the 3-year vs 5-year recommendation groups 6.
  • Another study published in 2019 found that the risk of advanced neoplasia following a small adenoma was lower than that following an advanced adenoma, and suggested that reducing the frequency of colonoscopy while providing regular fecal immunochemical testing (FIT) might be a more efficient use of resources for this population 7.
  • The updated guidelines for post-polypectomy colonoscopy surveillance published in 2021 recommend different surveillance intervals after detection of specific types of polyps, with the USMSTF recommending surveillance colonoscopies 7-10 years after diagnosis of 1-2 tubular adenomas <10 mm 8.
  • A study published in 2009 found that metachronous adenomas are generally smaller, usually tubular in shape, and bear high-grade dysplasia less often than initial adenomas, and suggested that regular follow-up colonoscopy can provide sufficient colorectal carcinoma prevention 9.

Factors Influencing Follow-up Recommendations

  • Factors that may influence the recommendation for a shorter surveillance interval include African American race, Asian/Pacific Islander ethnicity, detection of 2 adenomas at the index examination, more than 3 serrated polyps at the index examination, or index examination with fair or poor quality bowel preparation 6.
  • Family history of colorectal cancer and detection of 1-2 serrated polyps at the index examination may also be associated with a recommendation for a shorter surveillance interval 6.
  • A positive FIT was found to be an independent predictor of advanced neoplasia after a small adenoma at baseline colonoscopy 7.

References

Research

Post-polypectomy surveillance colonoscopy: Comparison of the updated guidelines.

United European gastroenterology journal, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.